In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on BridgeBio Pharma (BBIO), with a price target of ...
The post Mizuho Securities Maintains a Buy Rating on BridgeBio Pharma (BBIO) appeared first on Smarter Analyst.
In a report released today, Salim Syed from ...

https://www.smarteranalyst.com/new-blurbs/mizuho-securities-maintains-a-buy-rating-on-bridgebio-pharma-bbio/

#SmarterAnalyst